If you are building a long-term investment portfolio, focusing on high-quality ASX 200 shares with strong growth drivers can be a smart approach.
The best opportunities are often found in businesses with scale, strong management, and exposure to trends that can support earnings growth over many years.
Here are two ASX 200 shares that could be worth considering for the next five years.
Image source: Getty Images
ResMed Inc (ASX: RMD)
The first ASX 200 share that could be worth considering for the next five years is ResMed.
The sleep technology company is a global leader in devices and digital platforms used to treat sleep apnoea and other respiratory conditions. Its ecosystem combines medical devices, software, and cloud-connected data to help patients manage sleep-related health issues.
One of the most compelling aspects of the investment case is the size of the market opportunity. More than one billion people globally are estimated to suffer from sleep apnoea, yet a large portion of patients remain undiagnosed or untreated.
This underpenetrated market could provide a long runway for growth as awareness improves and diagnostic technology becomes more accessible. At the same time, wearable technology and digital health tools are helping identify more potential patients who may require treatment.
With strong global market leadership, a growing digital health ecosystem, and a massive addressable market, ResMed appears well positioned to continue expanding over the coming years.
Wesfarmers Ltd (ASX: WES)
Another ASX 200 share that could be worth considering by Aussie investors for the next five years is Wesfarmers.
The company is one of Australia's leading conglomerates, with a portfolio of well-known businesses including Bunnings, Kmart, Priceline, Target, and Officeworks. These brands have strong market positions and generate consistent cash flow, providing a solid foundation for the group.
One of Wesfarmers' key strengths is its disciplined capital allocation. Management has a track record of investing in growth opportunities while also returning capital to shareholders when appropriate.
In addition, the company has been investing in areas such as lithium and health, which could provide new avenues for growth beyond its core retail operations.
With a combination of defensive earnings from its retail businesses and optionality through new investments, Wesfarmers appears well placed to deliver steady returns over the next five years. This could make it worthy of a spot in a balanced investment portfolio.
